Article
CRISPR/Cas gene therapy.
Journal of cellular physiology - 1 Apr 2021
Zhang Baohong
Abstract excerpt
Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated enzyme (Cas) is a naturally occurring genome editing tool adopted from the prokaryotic adaptive immune defense system. Currently, CRISPR/Cas9-based genome editing has been becoming one of the most promising tools for treating human genetic diseases, including cardiovascular diseases, neuro-disorders, and cancers. As the quick...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
